(Q51470109)

English

Treatment with insulin glargine reduces asymptomatic hypoglycemia detected by continuous subcutaneous glucose monitoring in children and adolescents with type 1 diabetes.

scientific article published in June 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17550426

Treatment with insulin glargine reduces asymptomatic hypoglycemia detected by continuous subcutaneous glucose monitoring in children and adolescents with type 1 diabetes. (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17550426

type-1 diabetes

0 references

1 reference

based on heuristic

inferred from title

glucose monitoring

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

insulin glargine

1 reference

based on heuristic

inferred from title

author name string

Dorothee Deiss

1

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17550426

Olga Kordonouri

2

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17550426

Reinhard Hartmann

3

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17550426

Werner Hopfenmüller

4

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17550426

Kerstin Lüpke

5

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17550426

Thomas Danne

6

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17550426

publication date

1 June 2007

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17550426

Pediatric Diabetes

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17550426

8

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17550426

3

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17550426

157-162

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17550426

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2007.00252.X

21 January 2018

Long hypoglycaemic periods detected by subcutaneous continuous glucose monitoring in toddlers and pre-school children with diabetes mellitus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2007.00252.X

21 January 2018

Continuous subcutaneous glucose monitoring in children with type 1 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2007.00252.X

21 January 2018

Limitations of conventional methods of self-monitoring of blood glucose: lessons learned from 3 days of continuous glucose sensing in pediatric patients with type 1 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2007.00252.X

21 January 2018

Glycemic patterns detected by continuous subcutaneous glucose sensing in children and adolescents with type 1 diabetes mellitus treated by multiple daily injections vs continuous subcutaneous insulin infusion

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2007.00252.X

21 January 2018

Experience with insulin analogues in children

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2007.00252.X

21 January 2018

A randomized clinical trial comparing breakfast, dinner, or bedtime administration of insulin glargine in patients with type 1 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2007.00252.X

21 January 2018

The continuous glucose monitoring system is useful for detecting unrecognized hypoglycemias in patients with type 1 and type 2 diabetes but is not better than frequent capillary glucose measurements for improving metabolic control

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2007.00252.X

21 January 2018

Hypoglycemia prevalence in prepubertal children with type 1 diabetes on standard insulin regimen: use of continuous glucose monitoring system

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2007.00252.X

21 January 2018

Decreased epinephrine responses to hypoglycemia during sleep.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2007.00252.X

21 January 2018

Closing the gap: effect of diabetes case management on glycemic control among low-income ethnic minority populations: the California Medi-Cal type 2 diabetes study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2007.00252.X

21 January 2018

Accuracy of the modified Continuous Glucose Monitoring System (CGMS) sensor in an outpatient setting: results from a diabetes research in children network (DirecNet) study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2007.00252.X

21 January 2018

Subcutaneous glucose sensor values closely parallel blood glucose during insulin-induced hypoglycaemia.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2007.00252.X

21 January 2018

Randomized cross-over trial of insulin glargine plus lispro or NPH insulin plus regular human insulin in adolescents with type 1 diabetes on intensive insulin regimens

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2007.00252.X

21 January 2018

Intensive replacement of basal insulin in patients with type 1 diabetes given rapid-acting insulin analog at mealtime: a 3-month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2007.00252.X

21 January 2018

Improved glycaemic control with insulin glargine plus insulin lispro: a multicentre, randomized, cross-over trial in people with Type 1 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2007.00252.X

21 January 2018

Insulin lispro: a potential role in preventing nocturnal hypoglycaemia in young children with diabetes mellitus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2007.00252.X

21 January 2018

Hypoglycaemia with insulin aspart: a double-blind, randomised, crossover trial in subjects with Type 1 diabetes.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2007.00252.X

21 January 2018

Less hypoglycemia with insulin glargine in intensive insulin therapy for type 1 diabetes. U.S. Study Group of Insulin Glargine in Type 1 Diabetes.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2007.00252.X

21 January 2018

Basal insulin glargine (HOE 901) versus NPH insulin in patients with type 1 diabetes on multiple daily insulin regimens. U.S. Insulin Glargine (HOE 901) Type 1 Diabetes Investigator Group.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2007.00252.X

21 January 2018

Nocturnal blood glucose control in type I diabetes mellitus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2007.00252.X

21 January 2018

Assessment of glycemic control by continuous glucose monitoring system in 50 children with type 1 diabetes starting on insulin pump therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2007.00252.X

21 January 2018

Efficacy and safety of HOE 901 versus NPH insulin in patients with type 1 diabetes. The European Study Group of HOE 901 in type 1 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2007.00252.X

21 January 2018

A 16-week comparison of the novel insulin analog insulin glargine (HOE 901) and NPH human insulin used with insulin lispro in patients with type 1 diabetes.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2007.00252.X

21 January 2018

Nocturnal glucose control and free insulin levels in children with type 1 diabetes by use of the long-acting insulin HOE 901 as part of a three-injection regimen

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2007.00252.X

21 January 2018

Identifiers

10.1111/J.1399-5448.2007.00252.X

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17550426

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17550426

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51470109&oldid=1563399292"